{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,31]],"date-time":"2026-07-31T02:21:42Z","timestamp":1785464502189,"version":"3.56.0"},"reference-count":214,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2019,7,1]],"date-time":"2019-07-01T00:00:00Z","timestamp":1561939200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,7,1]],"date-time":"2019-07-01T00:00:00Z","timestamp":1561939200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100004837","name":"Ministerio de Ciencia e Innovaci\u00f3n","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004837","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Pharmacological Research"],"published-print":{"date-parts":[[2019,7]]},"DOI":"10.1016\/j.phrs.2019.104255","type":"journal-article","created":{"date-parts":[[2019,5,8]],"date-time":"2019-05-08T17:07:55Z","timestamp":1557335275000},"page":"104255","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":29,"special_numbering":"C","title":["A metabolic perspective of late onset Alzheimer\u2019s disease"],"prefix":"10.1016","volume":"145","author":[{"given":"Miren","family":"Ettcheto","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amanda","family":"Cano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Oriol","family":"Busquets","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Patricia Regina","family":"Manzine","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elena","family":"S\u00e1nchez-L\u00f3pez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rub\u00e9n D.","family":"Castro-Torres","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carlos","family":"Beas-Zarate","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ester","family":"Verdaguer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mar\u00eda Luisa","family":"Garc\u00eda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jordi","family":"Olloquequi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carme","family":"Auladell","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jaume","family":"Folch","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Antoni","family":"Camins","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.phrs.2019.104255_bib0005","first-page":"146","article-title":"\u00dcber eine eigenartige Erkrankung der Hirnrinde","volume":"64","author":"Alzheimer","year":"1907","journal-title":"Allgemeine Zeitschrift Fur Psychiatrie Und Psychisch-Gerichtliche Medizin"},{"key":"10.1016\/j.phrs.2019.104255_bib0010","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1111\/joim.12192","article-title":"Pathways to Alzheimer\u2019s disease","volume":"275","author":"Hardy","year":"2014","journal-title":"J. Intern. Med."},{"key":"10.1016\/j.phrs.2019.104255_bib0015","doi-asserted-by":"crossref","first-page":"1541","DOI":"10.1093\/oxfordjournals.jbchem.a135625","article-title":"One of the antigenic determinants of paired helical filaments is related to tau protein","volume":"99","author":"Nukina","year":"1986","journal-title":"J. Biochem"},{"key":"10.1016\/j.phrs.2019.104255_bib0020","doi-asserted-by":"crossref","first-page":"721","DOI":"10.1016\/j.tins.2014.08.004","article-title":"Lost after translation: missorting of tau protein and consequences for Alzheimer disease","volume":"37","author":"Zempel","year":"2014","journal-title":"Trends Neurosci."},{"key":"10.1016\/j.phrs.2019.104255_bib0025","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1111\/ene.13439","article-title":"Alzheimer\u2019s disease","volume":"25","author":"Lane","year":"2018","journal-title":"Eur. J. Neurol."},{"key":"10.1016\/j.phrs.2019.104255_bib0030","doi-asserted-by":"crossref","first-page":"504","DOI":"10.1016\/S0168-9525(00)89161-1","article-title":"Genetic susceptibility to Alzheimer disease","volume":"11","author":"Pericak-Vance","year":"1995","journal-title":"Trends Genetics"},{"key":"10.1016\/j.phrs.2019.104255_bib0035","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1016\/j.neurobiolaging.2005.08.021","article-title":"Insulin resistance syndrome and Alzheimer\u2019s disease: age- and obesity-related effects on memory, amyloid, and inflammation","volume":"1","author":"Craft","year":"2005","journal-title":"Neurobiol Aging, Suppl."},{"key":"10.1016\/j.phrs.2019.104255_bib0040","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1016\/j.neurobiolaging.2016.02.024","article-title":"Alzheimer\u2019s disease genetics consortium (ADGC). Assessment of the genetic variance of late-onset Alzheimer\u2019s disease","volume":"41","author":"Ridge","year":"2016","journal-title":"Neurobiol. Aging"},{"key":"10.1016\/j.phrs.2019.104255_bib0045","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1212\/WNL.50.1.164","article-title":"Cerebrospinal fluid and plasma insulin levels in Alzheimer\u2019s disease: relationship to severity of dementia and apolipoprotein E genotype","volume":"50","author":"Craft","year":"1998","journal-title":"Neurology"},{"key":"10.1016\/j.phrs.2019.104255_bib0050","first-page":"4","article-title":"Obesity accelerates Alzheimer-related pathology in APOE4 but not APOE3 mice","volume":"13","author":"Moser","year":"2017","journal-title":"eNeuro"},{"key":"10.1016\/j.phrs.2019.104255_bib0055","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1007\/s40265-016-0674-0","article-title":"Insulin resistance and neurodegeneration: progress towards the Development of New therapeutics for Alzheimer\u2019s disease","volume":"77","author":"de la Monte","year":"2017","journal-title":"Drugs"},{"key":"10.1016\/j.phrs.2019.104255_bib0060","doi-asserted-by":"crossref","first-page":"475","DOI":"10.5483\/BMBRep.2009.42.8.475","article-title":"Insulin resistance and Alzheimer\u2019s disease","volume":"42","author":"de la Monte","year":"2009","journal-title":"BMB Rep."},{"key":"10.1016\/j.phrs.2019.104255_bib0065","doi-asserted-by":"crossref","first-page":"1954","DOI":"10.1016\/j.euroneuro.2014.06.008","article-title":"Type 3 diabetes is sporadic Alzheimer\u2019s disease: mini-review","volume":"24","author":"de la Monte","year":"2014","journal-title":"Eur. Neuropsychopharmacol."},{"key":"10.1016\/j.phrs.2019.104255_bib0070","doi-asserted-by":"crossref","first-page":"89","DOI":"10.3233\/JAD-2006-10113","article-title":"Therapeutic rescue of neurodegeneration in experimental type 3 diabetes: relevance to Alzheimer\u2019s disease","volume":"10","author":"De la Monte","year":"2006","journal-title":"J. Alzheimer\u2019s Dis."},{"key":"10.1016\/j.phrs.2019.104255_bib0075","doi-asserted-by":"crossref","DOI":"10.1038\/nrdp.2015.19","article-title":"Type 2 diabetes mellitus","volume":"1","author":"DeFronzo","year":"2015","journal-title":"Nat. Rev. Dis. Primers"},{"key":"10.1016\/j.phrs.2019.104255_bib0080","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/j.phrs.2014.07.004","article-title":"The rise, fall, and resurgence of immunotherapy in type 1 diabetes","volume":"98","author":"Ben Nasr","year":"2015","journal-title":"Pharmacol. Res."},{"key":"10.1016\/j.phrs.2019.104255_bib0085","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1007\/s11892-011-0211-1","article-title":"Impact of islet transplantation on diabetes complications and quality of life","volume":"11","author":"Bassi","year":"2011","journal-title":"Curr. Diab. Rep."},{"key":"10.1016\/j.phrs.2019.104255_bib0090","doi-asserted-by":"crossref","first-page":"2476","DOI":"10.1093\/cercor\/bht101","article-title":"Altered expression of diabetes-related genes in Alzheimer\u2019s disease brains: Hisayama study","volume":"24","author":"Hokama","year":"2014","journal-title":"Cereb. Cortex"},{"key":"10.1016\/j.phrs.2019.104255_bib0095","doi-asserted-by":"crossref","first-page":"479","DOI":"10.3349\/ymj.2017.58.3.479","article-title":"Metabolism-centric overview of the pathogenesis of Alzheimer\u2019s disease","volume":"58","author":"Kang","year":"2017","journal-title":"Yonsei Med. J."},{"key":"10.1016\/j.phrs.2019.104255_bib0100","doi-asserted-by":"crossref","first-page":"482","DOI":"10.1016\/j.bbadis.2008.10.014","article-title":"Insulin resistance and amyloidogenesis as common molecular foundation for type 2 diabetes and Alzheimer\u2019s disease","volume":"1792","author":"Zhao","year":"2009","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.phrs.2019.104255_bib0105","doi-asserted-by":"crossref","first-page":"910","DOI":"10.1038\/mp.2015.129","article-title":"Midlife adiposity predicts earlier onset of Alzheimer\u2019s dementia, neuropathology and presymptomatic cerebral amyloid accumulation","volume":"21","author":"Chuang","year":"2016","journal-title":"Mol. Psychiatry"},{"key":"10.1016\/j.phrs.2019.104255_bib0110","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0032792","article-title":"Mechanisms underlying insulin deficiency-induced acceleration of \u03b2-amyloidosis in a mouse model of Alzheimer\u2019s disease","volume":"7","author":"Devi","year":"2012","journal-title":"PLoS One"},{"key":"10.1016\/j.phrs.2019.104255_bib0115","doi-asserted-by":"crossref","first-page":"1582","DOI":"10.2741\/e482","article-title":"Therapeutic targets of brain insulin resistance in sporadic Alzheimer\u2019s disease","volume":"4","author":"De la Monte","year":"2012","journal-title":"Front. Biosci."},{"key":"10.1016\/j.phrs.2019.104255_bib0120","doi-asserted-by":"crossref","first-page":"3927","DOI":"10.2337\/db15-0596","article-title":"Hippocampal insulin resistance impairs spatial learning and synaptic plasticity","volume":"64","author":"Grillo","year":"2015","journal-title":"Diabetes"},{"key":"10.1016\/j.phrs.2019.104255_bib0125","doi-asserted-by":"crossref","first-page":"430","DOI":"10.1111\/joim.12534","article-title":"Insulin signalling in Alzheimer\u2019s disease and diabetes: from epidemiology to molecular links","volume":"280","author":"Ribe","year":"2016","journal-title":"J. Intern. Med."},{"key":"10.1016\/j.phrs.2019.104255_bib0130","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1016\/j.neuron.2017.09.003","article-title":"Apolipoprotein E4 impairs neuronal insulin signaling by trapping insulin receptor in the endosomes","volume":"96","author":"Zhao","year":"2017","journal-title":"Neuron"},{"key":"10.1016\/j.phrs.2019.104255_bib0135","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1016\/j.ejphar.2004.02.049","article-title":"Glucose metabolism and insulin receptor signal transduction in Alzheimer disease","volume":"490","author":"Hoyer","year":"2004","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.phrs.2019.104255_bib0140","doi-asserted-by":"crossref","first-page":"1078","DOI":"10.1016\/j.bbadis.2016.08.018","article-title":"Is Alzheimer\u2019s disease a type 3 diabetes? A critical appraisal","volume":"1863","author":"Kandimalla","year":"2017","journal-title":"Biochim. Biophys. Actam."},{"key":"10.1016\/j.phrs.2019.104255_bib0145","doi-asserted-by":"crossref","first-page":"1090","DOI":"10.1016\/j.bbrc.2015.07.081","article-title":"The effect of isoliquiritigenin on learning and memory impairments induced by high-fat diet via inhibiting TNF-\u03b1\/JNK\/IRS signaling","volume":"464","author":"Ma","year":"2015","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.phrs.2019.104255_bib0150","doi-asserted-by":"crossref","first-page":"1687","DOI":"10.1016\/j.bbadis.2015.05.004","article-title":"High-fat diet-induced deregulation of hippocampal insulin signalling and mitochondrial homeostasis deficiencies contribute to Alzheimer disease pathology in rodents","volume":"1852","author":"Petrov","year":"2015","journal-title":"Biochim. Biophys. Acta."},{"key":"10.1016\/j.phrs.2019.104255_bib0155","doi-asserted-by":"crossref","first-page":"902","DOI":"10.1096\/fj.03-0978fje","article-title":"Diet-induced insulin resistance promotes amyloidosis in a transgenic mouse model of Alzheimer\u2019s disease","volume":"18","author":"Ho","year":"2004","journal-title":"FASEB J."},{"key":"10.1016\/j.phrs.2019.104255_bib0160","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1016\/j.endonu.2014.03.001","article-title":"Type 3 diabetes mellitus. The revival of inhaled insulin?","volume":"61","author":"Formiga","year":"2014","journal-title":"Endocrinol. Nutr."},{"key":"10.1016\/j.phrs.2019.104255_bib0165","doi-asserted-by":"crossref","first-page":"1184","DOI":"10.1126\/science.6338589","article-title":"Alzheimer\u2019s disease: a disorder of cortical cholinergic innervation","volume":"219","author":"Coyle","year":"1983","journal-title":"Science"},{"key":"10.1016\/j.phrs.2019.104255_bib0170","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1016\/S0006-3223(00)01101-X","article-title":"Galantamine, a cholinesterase inhibitor that allosterically modulates nicotinic receptors: effects on the course of Alzheimer\u2019s disease","volume":"49","author":"Coyle","year":"2001","journal-title":"Biol. Psychiatry"},{"key":"10.1016\/j.phrs.2019.104255_bib0175","doi-asserted-by":"crossref","first-page":"334","DOI":"10.1016\/j.bbr.2009.12.044","article-title":"The history of the cholinergic hypothesis","volume":"221","author":"Contestabile","year":"2011","journal-title":"Behav. Brain Res."},{"key":"10.1016\/j.phrs.2019.104255_bib0180","doi-asserted-by":"crossref","first-page":"1457","DOI":"10.1136\/bmj.2.6150.1457","article-title":"Correlation of cholinergic abnormalities with senile plaques and mental test scores in senile dementia","volume":"2","author":"Perry","year":"1978","journal-title":"BMJ"},{"key":"10.1016\/j.phrs.2019.104255_bib0185","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1002\/ana.410100203","article-title":"Alzheimer disease: evidence for selective loss of cholinergic neurons in the nucleus basalis","volume":"10","author":"Whitehouse","year":"1981","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.phrs.2019.104255_bib0190","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1186\/1471-2377-11-21","article-title":"Progressive cholinergic decline in Alzheimer\u2019s disease: consideration for treatment with donepezil 23 mg in patients with moderate to severe symptomatology","volume":"11","author":"Sabbagh","year":"2011","journal-title":"BMC Neurol."},{"key":"10.1016\/j.phrs.2019.104255_bib0195","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1126\/science.1072994","article-title":"The amyloid hypothesis of Alzheimer\u2019s disease: progress and problems on the road to therapeutics","volume":"297","author":"Hardy","year":"2002","journal-title":"Science"},{"key":"10.1016\/j.phrs.2019.104255_bib0200","doi-asserted-by":"crossref","first-page":"595","DOI":"10.15252\/emmm.201606210","article-title":"The amyloid hypothesis of Alzheimer\u2019s disease at 25 years","volume":"8","author":"Selkoe","year":"2016","journal-title":"EMBO Mol. Med."},{"key":"10.1016\/j.phrs.2019.104255_bib0205","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1126\/science.1566067","article-title":"Alzheimer\u2019s disease: the amyloid cascade hypothesis","volume":"256","author":"Hardy","year":"1992","journal-title":"Science"},{"key":"10.1016\/j.phrs.2019.104255_bib0210","doi-asserted-by":"crossref","first-page":"1129","DOI":"10.1111\/j.1471-4159.2009.06181.x","article-title":"The amyloid hypothesis for Alzheimer\u2019s disease: a critical reappraisal","volume":"110","author":"Hardy","year":"2009","journal-title":"J. Neurochem."},{"key":"10.1016\/j.phrs.2019.104255_bib0215","doi-asserted-by":"crossref","first-page":"789","DOI":"10.1126\/science.1074069","article-title":"Alzheimer\u2019s disease is a synaptic failure","volume":"298","author":"Selkoe","year":"2002","journal-title":"Science"},{"key":"10.1016\/j.phrs.2019.104255_bib0220","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1186\/alzrt244","article-title":"Interpreting Alzheimer\u2019s disease clinical trials in light of the effects on amyloid-\u03b2","volume":"6","author":"Toyn","year":"2014","journal-title":"Alzheimers Res. Ther."},{"key":"10.1016\/j.phrs.2019.104255_bib0225","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1038\/nature19323","article-title":"The antibody aducanumab reduces A\u03b2 plaques in Alzheimer\u2019s disease","volume":"537","author":"Sevigny","year":"2016","journal-title":"Nature"},{"key":"10.1016\/j.phrs.2019.104255_bib0230","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1016\/j.neuint.2017.04.020","article-title":"Bidirectional interactions between diabetes and Alzheimer\u2019s disease","volume":"108","author":"Shinohara","year":"2017","journal-title":"Neurochem. Int."},{"key":"10.1016\/j.phrs.2019.104255_bib0235","doi-asserted-by":"crossref","first-page":"1691","DOI":"10.1056\/NEJMoa1706441","article-title":"Randomized trial of verubecestat for mild-to-moderate Alzheimer\u2019s disease","volume":"378","author":"Egan","year":"2018","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.phrs.2019.104255_bib0240","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1016\/j.trci.2018.03.009","article-title":"Alzheimer\u2019s disease drug development pipeline; 2018","volume":"4","author":"Cummings","year":"2018","journal-title":"Alzheimers Dement (N Y)"},{"key":"10.1016\/j.phrs.2019.104255_bib0245","doi-asserted-by":"crossref","first-page":"1858","DOI":"10.1073\/pnas.72.5.1858","article-title":"A protein factor essential for microtubule assembly","volume":"72","author":"Weingarten","year":"1975","journal-title":"Proc. Natl. Acad. Sci. U S A."},{"key":"10.1016\/j.phrs.2019.104255_bib0250","doi-asserted-by":"crossref","first-page":"5819","DOI":"10.1073\/pnas.1017033108","article-title":"Soluble amyloid beta-protein dimers isolated from Alzheimer cortex directly induce tau hyperphosphorylation and neuritic degeneration","volume":"108","author":"Jin","year":"2011","journal-title":"Proc. Natl. Acad. Sci. U S A."},{"key":"10.1016\/j.phrs.2019.104255_bib0255","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1517\/14728222.2014.870156","article-title":"Microtubule-associated protein tau as a therapeutic target in Alzheimer\u2019s disease","volume":"18","author":"Iqbal","year":"2014","journal-title":"Expert Opinion Ther. Targets"},{"key":"10.1016\/j.phrs.2019.104255_bib0260","doi-asserted-by":"crossref","first-page":"851","DOI":"10.1016\/S0531-5565(00)00147-9","article-title":"Density profiles of Alzheimer disease regional brain pathology for the huddinge brain bank: pattern recognition emulates and expands upon braak staging","volume":"35","author":"Corder","year":"2000","journal-title":"Exp. Gerontol."},{"issue":"41","key":"10.1016\/j.phrs.2019.104255_bib0265","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1002\/ana.410410106","article-title":"Neuronal loss correlates with but exceeds neurofibrillary tangles in Alzheimer\u2019s disease","volume":"41","author":"G\u00f3mez-Isla","year":"1997","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.phrs.2019.104255_bib0270","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1016\/0022-510X(86)90167-X","article-title":"Alzheimer\u2019s disease: tau proteins, the promoting factors of microtubule assembly, are major components of paired helical filaments","volume":"76","author":"Delacourte","year":"1986","journal-title":"J. Neurol. Sci."},{"key":"10.1016\/j.phrs.2019.104255_bib0275","doi-asserted-by":"crossref","first-page":"750","DOI":"10.1126\/science.1141736","article-title":"Reducing endogenous tau ameliorates amyloid beta-induced deficits in an Alzheimer\u2019s disease mouse model","volume":"316","author":"Robertson","year":"2007","journal-title":"Science"},{"key":"10.1016\/j.phrs.2019.104255_bib0280","doi-asserted-by":"crossref","first-page":"388","DOI":"10.1016\/S1474-4422(15)70016-5","article-title":"Neuroinflammation in Alzheimer\u2019s disease","volume":"14","author":"Heneka","year":"2015","journal-title":"Lancet Neurol."},{"key":"10.1016\/j.phrs.2019.104255_bib0285","doi-asserted-by":"crossref","first-page":"3653","DOI":"10.2337\/dbi15-0011","article-title":"A key role of insulin receptors in memory","volume":"64","author":"De Felice","year":"2015","journal-title":"Diabetes."},{"key":"10.1016\/j.phrs.2019.104255_bib0290","doi-asserted-by":"crossref","first-page":"S26","DOI":"10.1016\/j.jalz.2013.12.004","article-title":"How does brain insulin resistance develop in Alzheimer\u2019s disease?","volume":"10","author":"De Felice","year":"2014","journal-title":"Alzheimers Dement."},{"key":"10.1016\/j.phrs.2019.104255_bib0295","first-page":"367","article-title":"Alzheimer\u2019s disease facts and figures","volume":"14","author":"Alzheimer\u2019s Association Report 2018","year":"2018","journal-title":"Alzheimer\u2019s Dement."},{"key":"10.1016\/j.phrs.2019.104255_bib0300","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1016\/S0197-4580(00)00124-X","article-title":"Inflammation and Alzheimer\u2019s disease","volume":"21","author":"Akiyama","year":"2000","journal-title":"Neurobiol. Aging"},{"issue":"Suppl. 1","key":"10.1016\/j.phrs.2019.104255_bib0305","doi-asserted-by":"crossref","first-page":"S64","DOI":"10.1007\/s10875-014-0032-5","article-title":"Neuroinflammation in Alzheimer\u2019s disease: from pathogenesis to a therapeutic target","volume":"34","author":"Pimplikar","year":"2014","journal-title":"J. Clin. Immunol."},{"key":"10.1016\/j.phrs.2019.104255_bib0310","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1038\/nri3705","article-title":"Innate immune activation in neurodegenerative disease","volume":"14","author":"Heneka","year":"2014","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.phrs.2019.104255_bib0315","doi-asserted-by":"crossref","first-page":"1442","DOI":"10.1093\/brain\/awh452","article-title":"Acute treatment with the PPARgamma agonist pioglitazone and ibuprofen reduces glial inflammation and Abeta1-42 levels in APPV717I transgenic mice","volume":"125","author":"Heneka","year":"2005","journal-title":"Brain"},{"key":"10.1016\/j.phrs.2019.104255_bib0320","doi-asserted-by":"crossref","first-page":"1219","DOI":"10.3233\/JAD-170706","article-title":"Alzheimer\u2019s disease can Be spared by nonsteroidal anti-inflammatory drugs","volume":"62","author":"McGeer","year":"2018","journal-title":"J. Alzheimers Dis."},{"key":"10.1016\/j.phrs.2019.104255_bib0325","doi-asserted-by":"crossref","first-page":"4427","DOI":"10.1523\/JNEUROSCI.12-11-04427.1992","article-title":"Open-channel block of N-methyl-D-aspartate (NMDA) responses by memantine: therapeutic advantage against NMDA receptor-mediated neurotoxicity","volume":"12","author":"Chen","year":"1992","journal-title":"J. Neurosci."},{"key":"10.1016\/j.phrs.2019.104255_bib0330","doi-asserted-by":"crossref","first-page":"614","DOI":"10.1046\/j.1471-4159.1995.64020614.x","article-title":"Regional variations in the pharmacology of NMDA receptor channel blockers: implications for therapeutic potential","volume":"64","author":"Porter","year":"1995","journal-title":"J. Neurochem."},{"key":"10.1016\/j.phrs.2019.104255_bib0335","doi-asserted-by":"crossref","first-page":"324","DOI":"10.1111\/j.1476-5381.2012.02057.x","article-title":"Alzheimer\u2019s disease, \u03b2-amyloid, glutamate, NMDA receptors and memantine-searching for the connections","volume":"167","author":"Danysz","year":"2012","journal-title":"British J. Pharmacol."},{"key":"10.1016\/j.phrs.2019.104255_bib0340","doi-asserted-by":"crossref","first-page":"699","DOI":"10.1016\/j.neuropharm.2007.07.013","article-title":"Memantine: a NMDA receptor antagonist that improves memory by restoration of homeostasis in the glutamatergic system\u2014too little activation is bad, too much is even worse","volume":"53","author":"Parsons","year":"2007","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.phrs.2019.104255_bib0345","doi-asserted-by":"crossref","first-page":"1234","DOI":"10.1001\/archneur.1997.00550220042012","article-title":"Excitotoxic neurodegeneration in Alzheimer disease. New hypothesis and new therapeutic strategies","volume":"54","author":"Olney","year":"1997","journal-title":"Archives Neurol."},{"key":"10.1016\/j.phrs.2019.104255_bib0350","doi-asserted-by":"crossref","first-page":"1051","DOI":"10.1038\/nn1503","article-title":"Regulation of NMDA receptor trafficking by amyloid-beta","volume":"8","author":"Snyder","year":"2005","journal-title":"Nat. Neurosci."},{"key":"10.1016\/j.phrs.2019.104255_bib0355","doi-asserted-by":"crossref","first-page":"1392","DOI":"10.1007\/s001250050588","article-title":"Association of diabetes mellitus and dementia: the Rotterdam study","volume":"39","author":"Ott","year":"1996","journal-title":"Diabetologia"},{"key":"10.1016\/j.phrs.2019.104255_bib0360","doi-asserted-by":"crossref","first-page":"1937","DOI":"10.1212\/WNL.53.9.1937","article-title":"Diabetes mellitus and the risk of dementia: the Rotterdam study","volume":"53","author":"Ott","year":"1999","journal-title":"Neurology"},{"key":"10.1016\/j.phrs.2019.104255_bib0365","doi-asserted-by":"crossref","first-page":"1982","DOI":"10.1212\/WNL.0b013e3181ffe4f6","article-title":"Insulin metabolism and the risk of Alzheimer disease: the Rotterdam study","volume":"75","author":"Schrijvers","year":"2010","journal-title":"Neurology"},{"key":"10.1016\/j.phrs.2019.104255_bib0370","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1038\/ijo.2017.231","article-title":"Triglycerides cross the blood-brain barrier and induce central leptin and insulin receptor resistance","volume":"42","author":"Banks","year":"2018","journal-title":"Int. J. Obes."},{"key":"10.1016\/j.phrs.2019.104255_bib0375","doi-asserted-by":"crossref","first-page":"739","DOI":"10.3233\/JAD-141086","article-title":"2003-2013: a decade of body mass index, Alzheimer\u2019s disease, and dementia","volume":"43","author":"Emmerzaal","year":"2015","journal-title":"J. Alzheimers Dis."},{"key":"10.1016\/j.phrs.2019.104255_bib0380","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1001\/archinte.165.3.321","article-title":"Body mass index, other cardiovascular risk factors, and hospitalization for dementia","volume":"165","author":"Rosengren","year":"2005","journal-title":"Arch. Intern. Med."},{"key":"10.1016\/j.phrs.2019.104255_bib0385","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1093\/ageing\/afl123","article-title":"The risk of dementia with increased body mass index","volume":"36","author":"Gorospe","year":"2007","journal-title":"Age Ageing"},{"key":"10.1016\/j.phrs.2019.104255_bib0390","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1016\/j.jalz.2017.06.2637","article-title":"Obesity trajectories and risk of dementia: 28 years of follow-up in the whitehall II study","volume":"14","author":"Singh-Manoux","year":"2018","journal-title":"Alzheimers Dement."},{"key":"10.1016\/j.phrs.2019.104255_bib0395","doi-asserted-by":"crossref","first-page":"1556","DOI":"10.1001\/archneur.62.10.1556","article-title":"Obesity and vascular risk factors at midlife and the risk of dementia and Alzheimer disease","volume":"62","author":"Kivipelto","year":"2005","journal-title":"Arch. Neurol."},{"key":"10.1016\/j.phrs.2019.104255_bib0400","doi-asserted-by":"crossref","first-page":"363","DOI":"10.2147\/VHRM.S1839","article-title":"Vascular risk factors, cognitve decline, and dementia","volume":"4","author":"Duron","year":"2008","journal-title":"Vasc Health Risk Manag."},{"key":"10.1016\/j.phrs.2019.104255_bib0405","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1186\/s12916-014-0218-y","article-title":"Vascular risk factors and Alzheimer\u2019s disease","volume":"12","author":"O\u2019Brien","year":"2014","journal-title":"BMC Med."},{"key":"10.1016\/j.phrs.2019.104255_bib0410","doi-asserted-by":"crossref","first-page":"S76","DOI":"10.1016\/j.jalz.2013.12.010","article-title":"Inflammation, defective insulin signaling, and neuronal dysfunction in Alzheimer\u2019s disease","volume":"10","author":"Ferreira","year":"2014","journal-title":"Alzheimers Dement."},{"key":"10.1016\/j.phrs.2019.104255_bib0415","doi-asserted-by":"crossref","first-page":"6448","DOI":"10.1073\/pnas.95.11.6448","article-title":"Diffusible, nonfibrillar ligands derived from Abeta1-42 are potent central nervous system neurotoxins","volume":"95","author":"Lambert","year":"1998","journal-title":"Proc. Natl. Acad. Sci. U S A."},{"key":"10.1016\/j.phrs.2019.104255_bib0420","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1016\/j.nlm.2011.08.003","article-title":"The a\u03b2 oligomer hypothesis for synapse failure and memory loss in Alzheimer\u2019s disease","volume":"96","author":"Ferreira","year":"2011","journal-title":"Neurobiol. Learn Mem."},{"key":"10.1016\/j.phrs.2019.104255_bib0425","doi-asserted-by":"crossref","first-page":"332","DOI":"10.1080\/15216540701283882","article-title":"Soluble protein oligomers as emerging toxins in Alzheimer\u2019s and other amyloid diseases","volume":"59","author":"Ferreira","year":"2007","journal-title":"IUBMB Life"},{"key":"10.1016\/j.phrs.2019.104255_bib0430","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1007\/s00401-015-1386-3","article-title":"Amyloid \u03b2-oligomers in Alzheimer\u2019s disease pathogenesis, treatment, and diagnosis","volume":"129","author":"Viola","year":"2015","journal-title":"Acta Neuropathol."},{"key":"10.1016\/j.phrs.2019.104255_bib0435","doi-asserted-by":"crossref","first-page":"831","DOI":"10.1016\/j.cmet.2013.11.002","article-title":"TNF-\u03b1 mediates PKR-dependent memory impairment and brain IRS-1 inhibition induced by Alzheimer\u2019s \u03b2-amyloid oligomers in mice and monkeys","volume":"18","author":"Lourenco","year":"2013","journal-title":"Cell Metab."},{"key":"10.1016\/j.phrs.2019.104255_bib0440","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/j.pneurobio.2015.03.003","article-title":"Neuronal stress signaling and eIF2\u03b1 phosphorylation as molecular links between Alzheimer\u2019s disease and diabetes","volume":"129","author":"Lourenco","year":"2015","journal-title":"Prog. Neurobiol."},{"key":"10.1016\/j.phrs.2019.104255_bib0445","doi-asserted-by":"crossref","first-page":"S567","DOI":"10.3233\/JAD-179941","article-title":"The amyloid-\u03b2 oligomer hypothesis: beginning of the third decade","volume":"64","author":"Cline","year":"2018","journal-title":"J. Alzheimers Dis."},{"key":"10.1016\/j.phrs.2019.104255_bib0450","doi-asserted-by":"crossref","first-page":"723","DOI":"10.2174\/1567205012666150710115506","article-title":"Insulin resistance as Common molecular denominator linking obesity to Alzheimer\u2019s disease","volume":"12","author":"Nuzzo","year":"2015","journal-title":"Curr. Alzheimer Res."},{"key":"10.1016\/j.phrs.2019.104255_bib0455","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1016\/j.mad.2016.11.002","article-title":"Long-term exposition to a high fat diet favors the appearance of \u03b2-amyloid depositions in the brain of C57BL\/6J mice. A potential model of sporadic Alzheimer\u2019s disease","volume":"162","author":"Busquets","year":"2017","journal-title":"Mech. Ageing Dev."},{"key":"10.1016\/j.phrs.2019.104255_bib0460","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1016\/j.nbd.2014.03.011","article-title":"High fat diet produces brain insulin resistance, synaptodendritic abnormalities and altered behavior in mice","volume":"67","author":"Arnold","year":"2014","journal-title":"Neurobiol. Dis."},{"key":"10.1016\/j.phrs.2019.104255_bib0465","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1016\/j.bbi.2015.08.023","article-title":"Dietary obesity reversibly induces synaptic stripping by microglia and impairs hippocampal plasticity","volume":"51","author":"Hao","year":"2016","journal-title":"Brain Behav. Immun."},{"key":"10.1016\/j.phrs.2019.104255_bib0470","doi-asserted-by":"crossref","first-page":"1291","DOI":"10.1016\/j.bbagen.2016.03.005","article-title":"Intrahippocampal administration of a domain antibody that binds aggregated amyloid-\u03b2 reverses cognitive deficits produced by diet-induced obesity","volume":"1860","author":"Osborne","year":"2016","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.phrs.2019.104255_bib0475","doi-asserted-by":"crossref","first-page":"1821","DOI":"10.1016\/j.neurobiolaging.2014.02.010","article-title":"High-fat diet-induced memory impairment in triple-transgenic Alzheimer\u2019s disease (3xTgAD) mice is independent of changes in amyloid and tau pathology","volume":"35","author":"Knight","year":"2014","journal-title":"Neurobiol. Aging"},{"key":"10.1016\/j.phrs.2019.104255_bib0480","doi-asserted-by":"crossref","first-page":"4273","DOI":"10.1096\/fj.14-268482","article-title":"Age-dependent impairment of glucose tolerance in the 3xTg-AD mouse model of Alzheimer\u2019s disease","volume":"29","author":"Vandal","year":"2015","journal-title":"FASEB J."},{"key":"10.1016\/j.phrs.2019.104255_bib0485","doi-asserted-by":"crossref","first-page":"612","DOI":"10.1038\/nrneurol.2017.111","article-title":"A systemic view of Alzheimer disease - insights from amyloid-\u03b2 metabolism beyond the brain","volume":"13","author":"Wang","year":"2017","journal-title":"Nat. Rev. Neurol."},{"key":"10.1016\/j.phrs.2019.104255_bib0490","doi-asserted-by":"crossref","first-page":"1159","DOI":"10.2337\/db12-0670","article-title":"Amyloid-\u03b2 induces hepatic insulin resistance in vivo via JAK2","volume":"62","author":"Zhang","year":"2013","journal-title":"Diabetes"},{"key":"10.1016\/j.phrs.2019.104255_bib0495","doi-asserted-by":"crossref","first-page":"1434","DOI":"10.2337\/db11-0499","article-title":"Amyloid-\u03b2 induces hepatic insulin resistance by activating JAK2\/STAT3\/SOCS-1 signaling pathway","volume":"61","author":"Zhang","year":"2012","journal-title":"Diabetes"},{"key":"10.1016\/j.phrs.2019.104255_bib0500","doi-asserted-by":"crossref","first-page":"11120","DOI":"10.1523\/JNEUROSCI.2860-04.2004","article-title":"S.A. Frautschy G.M., Cole GM. Insulin-degrading enzyme as a downstream target of insulin receptor signaling cascade: implications for Alzheimer\u2019s disease intervention","volume":"24","author":"Zhao","year":"2004","journal-title":"J. Neurosci."},{"key":"10.1016\/j.phrs.2019.104255_bib0505","first-page":"10","article-title":"High-fat diet induces hepatic insulin resistance and impairment of synaptic plasticity","volume":"10","author":"Liu","year":"2015","journal-title":"PLoS One"},{"key":"10.1016\/j.phrs.2019.104255_bib0510","doi-asserted-by":"crossref","first-page":"851","DOI":"10.1016\/j.jalz.2016.01.008","article-title":"Increased susceptibility to metabolic dysregulation in a mouse model of Alzheimer\u2019s disease is associated with impaired hypothalamic insulin signaling and elevated BCAA levels","volume":"12","author":"Ruiz","year":"2016","journal-title":"Alzheimers Dement."},{"key":"10.1016\/j.phrs.2019.104255_bib0515","doi-asserted-by":"crossref","first-page":"958","DOI":"10.1002\/iub.1097","article-title":"Peroxisome proliferator-activated receptor-\u03b3 cofactors in neurodegeneration","volume":"64","author":"Katsouri","year":"2012","journal-title":"IUBMB Life"},{"key":"10.1016\/j.phrs.2019.104255_bib0520","doi-asserted-by":"crossref","first-page":"12292","DOI":"10.1073\/pnas.1606171113","article-title":"PPAR\u03b3-coactivator-1\u03b1 gene transfer reduces neuronal loss and amyloid-\u03b2 generation by reducing \u03b2-secretase in an Alzheimer\u2019s disease model","volume":"113","author":"Katsouri","year":"2016","journal-title":"Proc. Natl. Acad. Sci. U S A."},{"key":"10.1016\/j.phrs.2019.104255_bib0525","doi-asserted-by":"crossref","first-page":"151","DOI":"10.3233\/JAD-2011-101356","article-title":"PPAR\u03b3 co-activator-1\u03b1 (PGC-1\u03b1) reduces amyloid-\u03b2 generation through a PPAR\u03b3-dependent mechanism","volume":"25","author":"Katsouri","year":"2011","journal-title":"J. Alzheimers Dis."},{"issue":"66","key":"10.1016\/j.phrs.2019.104255_bib0530","first-page":"352","article-title":"PGC-1alpha expression decreases in the Alzheimer disease brain as a function of dementia","volume":"66","author":"Qin","year":"2009","journal-title":"Archives Neurol."},{"key":"10.1016\/j.phrs.2019.104255_bib0535","doi-asserted-by":"crossref","first-page":"915","DOI":"10.3233\/JAD-160640","article-title":"Mitochondrial abnormalities and synaptic loss underlie memory deficits seen in mouse models of obesity and Alzheimer\u2019s disease","volume":"55","author":"Martins","year":"2017","journal-title":"J. Alzheimers Dis."},{"key":"10.1016\/j.phrs.2019.104255_bib0540","doi-asserted-by":"crossref","first-page":"731","DOI":"10.1016\/j.bbrc.2017.08.122","article-title":"Effect of high-fat diet on cognitive impairment in triple-transgenic mice model of Alzheimer\u2019s disease","volume":"493","author":"Sah","year":"2017","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.phrs.2019.104255_bib0545","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1161\/JAHA.115.003154","article-title":"High-fat-diet intake enhances cerebral amyloid angiopathy and cognitive impairment in a mouse model of Alzheimer\u2019s disease, independently of metabolic disorders","volume":"5","author":"Lin","year":"2016","journal-title":"J. Am. Heart Assoc."},{"key":"10.1016\/j.phrs.2019.104255_bib0550","doi-asserted-by":"crossref","first-page":"67808","DOI":"10.18632\/oncotarget.12179","article-title":"High fat diet exacerbates Alzheimer\u2019s disease-related pathology in APPswe\/PS1 mice","volume":"7","author":"Th\u00e9riault","year":"2016","journal-title":"Oncotarget"},{"key":"10.1016\/j.phrs.2019.104255_bib0555","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1016\/j.bbadis.2016.10.006","article-title":"High fat diet induces brain insulin resistance and cognitive impairment in mice","volume":"1863","author":"Kothari","year":"2017","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.phrs.2019.104255_bib0560","doi-asserted-by":"crossref","first-page":"1532","DOI":"10.1210\/en.2009-1196","article-title":"Increased food intake leads to obesity and insulin resistance in the tg2576 Alzheimer\u2019s disease mouse model","volume":"151","author":"Kohjima","year":"2010","journal-title":"Endocrinology"},{"key":"10.1016\/j.phrs.2019.104255_bib0565","doi-asserted-by":"crossref","first-page":"715","DOI":"10.3233\/JAD-2009-0984","article-title":"Hepatic ceramide May mediate brain insulin resistance and neurodegeneration in type 2 diabetes and Non-alcoholic steatohepatitis","volume":"16","author":"Lyn-Cook","year":"2009","journal-title":"J. Alzheimers Dis."},{"key":"10.1016\/j.phrs.2019.104255_bib0570","first-page":"53","article-title":"The role of insulin resistance and glucose metabolism dysregulation in the development of Alzheimer\u2019s disease","volume":"68","author":"Arrieta-Cruz","year":"2016","journal-title":"Rev. Investig. Clin."},{"key":"10.1016\/j.phrs.2019.104255_bib0575","doi-asserted-by":"crossref","first-page":"843","DOI":"10.3233\/JAD-131865","article-title":"Acute exposure of the mediobasal hypothalamus to amyloid-\u03b225\u201335 perturbs hepatic glucose metabolism","volume":"46","author":"Arrieta-Cruz","year":"2015","journal-title":"J. Alzheimers Dis."},{"key":"10.1016\/j.phrs.2019.104255_bib0580","doi-asserted-by":"crossref","first-page":"190","DOI":"10.15252\/emmm.201404183","article-title":"Alzheimer-associated a\u03b2 oligomers impact the central nervous system to induce peripheral metabolic deregulation","volume":"7","author":"Clarke","year":"2015","journal-title":"EMBO Mol. Med."},{"key":"10.1016\/j.phrs.2019.104255_bib0585","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1016\/j.jalz.2008.10.004","article-title":"Amyloid beta peptides in human plasma and tissues and their significance for Alzheimer\u2019s disease","volume":"5","author":"Roher","year":"2009","journal-title":"Alzheimers Dement."},{"key":"10.1016\/j.phrs.2019.104255_bib0590","doi-asserted-by":"crossref","first-page":"1503","DOI":"10.1016\/j.neurobiolaging.2008.08.019","article-title":"Beta amyloid and hyperphosphorylated tau deposits in the pancreas in type 2 diabetes","volume":"31","author":"Miklossy","year":"2010","journal-title":"Neurobiol. Aging"},{"key":"10.1016\/j.phrs.2019.104255_bib0595","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1016\/j.neuint.2017.04.020","article-title":"Bidirectional interactions between diabetes and Alzheimer\u2019s disease","volume":"108","author":"Shinohara","year":"2017","journal-title":"Neurochem Int."},{"key":"10.1016\/j.phrs.2019.104255_bib0600","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1007\/s00401-017-1694-x","article-title":"IRE1 signaling exacerbates Alzheimer\u2019s disease pathogenesis","volume":"134","author":"Duran-Aniotz","year":"2017","journal-title":"Acta Neuropathol."},{"key":"10.1016\/j.phrs.2019.104255_bib0605","doi-asserted-by":"crossref","first-page":"8","DOI":"10.3389\/fnagi.2014.00008","article-title":"Memory loss in Alzheimer\u2019 s disease: are the alterations in the UPR network involved in the cognitive impairment?","volume":"6","author":"Duran-Aniotz","year":"2014","journal-title":"Front. Aging Neurosci."},{"key":"10.1016\/j.phrs.2019.104255_bib0610","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1007\/s00281-013-0373-9","article-title":"The unfolded protein response in Alzheimer\u2019s disease","volume":"35","author":"Cornejo","year":"2013","journal-title":"Semin Immunopathol."},{"key":"10.1016\/j.phrs.2019.104255_bib0615","doi-asserted-by":"crossref","first-page":"1215","DOI":"10.1046\/j.1471-4159.2002.01237.x","article-title":"Involvement of double-stranded RNA-dependent protein kinase and phosphorylation of eukaryotic initiation factor-2alpha in neuronal degeneration","volume":"83","author":"Chang","year":"2002","journal-title":"J. Neurochem."},{"key":"10.1016\/j.phrs.2019.104255_bib0620","doi-asserted-by":"crossref","first-page":"995","DOI":"10.1111\/febs.14332","article-title":"Emerging roles of ER stress in the etiology and pathogenesis of Alzheimer\u2019s disease","volume":"285","author":"Gerakis","year":"2018","journal-title":"FEBS J."},{"key":"10.1016\/j.phrs.2019.104255_bib0625","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1038\/nrneurol.2017.99","article-title":"ER stress and the unfolded protein response in neurodegeneration","volume":"13","author":"Hetz","year":"2017","journal-title":"Nat. Rev. Neurol."},{"key":"10.1016\/j.phrs.2019.104255_bib0630","doi-asserted-by":"crossref","first-page":"988","DOI":"10.1016\/j.neuron.2008.10.047","article-title":"Phosphorylation of the translation initiation factor eIF2a increases BACE1 levels and promotes amyloidogenesis","volume":"60","author":"O\u2019Connor","year":"2008","journal-title":"Neuron"},{"key":"10.1016\/j.phrs.2019.104255_bib0635","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1016\/j.brainres.2016.04.064","article-title":"Gene therapy to target ER stress in brain diseases","volume":"1648","author":"Valenzuela","year":"2016","journal-title":"Brain Res."},{"issue":"201","key":"10.1016\/j.phrs.2019.104255_bib0640","doi-asserted-by":"crossref","first-page":"1658","DOI":"10.1016\/j.bbi.2011.06.009","article-title":"Ursolic acid improves high fat diet-induced cognitive impairments by blocking endoplasmic reticulum stress and I\u03baB kinase \u03b2\/nuclear factor-\u03baB-mediated inflammatory pathways in mice","volume":"25","author":"Lu","year":"2011","journal-title":"Brain Behav. Immun."},{"key":"10.1016\/j.phrs.2019.104255_bib0645","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1186\/s13195-017-0308-0","article-title":"PKR involvement in Alzheimer\u2019s disease","volume":"9","author":"Hugon","year":"2017","journal-title":"Alzheimers Res. Ther."},{"key":"10.1016\/j.phrs.2019.104255_bib0650","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1186\/s13041-017-0338-3","article-title":"Restoring synaptic plasticity and memory in mouse models of Alzheimer\u2019s disease by PKR inhibition","volume":"10","author":"Hwang","year":"2017","journal-title":"Mol. Brain"},{"key":"10.1016\/j.phrs.2019.104255_bib0655","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0012974","article-title":"Phospho-eIF2a level is important for determining abilities of BACE1 reduction to rescue cholinergic neurodegeneration and memory defects in 5XFAD mice","volume":"5","author":"Devi","year":"2010","journal-title":"PLoS One"},{"key":"10.1016\/j.phrs.2019.104255_bib0660","doi-asserted-by":"crossref","first-page":"e284","DOI":"10.1038\/tp.2013.59","article-title":"Mechanisms that lessen benefits of \u03b2-secretase reduction in a mouse model of Alzheimer\u2019s disease","volume":"3","author":"Devi","year":"2013","journal-title":"Transl. Psychiatry"},{"key":"10.1016\/j.phrs.2019.104255_bib0665","doi-asserted-by":"crossref","first-page":"2272","DOI":"10.1016\/j.neurobiolaging.2014.04.031","article-title":"PERK mediates eIF2\u03b1 phosphorylation responsible for BACE1 elevation, CREB dysfunction and neurodegeneration in a mouse model of Alzheimer\u2019s disease","volume":"35","author":"Devi","year":"2014","journal-title":"Neurobiol. Aging"},{"key":"10.1016\/j.phrs.2019.104255_bib0670","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/j.neurobiolaging.2016.02.005","article-title":"Repression of the eIF2\u03b1 kinase PERK alleviates mGluR-LTD impairments in a mouse model of Alzheimer\u2019s disease","volume":"41","author":"Yang","year":"2016","journal-title":"Neurobiol. Aging"},{"key":"10.1016\/j.phrs.2019.104255_bib0675","doi-asserted-by":"crossref","first-page":"885","DOI":"10.1016\/j.bbadis.2012.01.009","article-title":"Oxidative stress increases BACE1 protein levels through activation of the PKR-eIF2\u03b1 pathway","volume":"1822","author":"Mouton-Liger","year":"2012","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.phrs.2019.104255_bib0680","doi-asserted-by":"crossref","first-page":"1299","DOI":"10.1038\/nn.3486","article-title":"Suppression of eIF2\u03b1 kinases alleviates Alzheimer\u2019s disease-related plasticity and memory deficits","volume":"16","author":"Ma","year":"2013","journal-title":"Nat. Neurosci."},{"key":"10.1016\/j.phrs.2019.104255_bib0685","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1016\/j.expneurol.2016.01.007","article-title":"The role of endoplasmic reticulum stress in hippocampal insulin resistance","volume":"277","author":"Sims-Robinson","year":"2016","journal-title":"Exp. Neurol."},{"key":"10.1016\/j.phrs.2019.104255_bib0690","doi-asserted-by":"crossref","first-page":"440","DOI":"10.1016\/j.neuropharm.2017.10.030","article-title":"JNK1 inhibition by Licochalcone A leads to neuronal protection against excitotoxic insults derived of kainic acid","volume":"131","author":"Busquets","year":"2018","journal-title":"Neuropharmacology"},{"issue":"5","key":"10.1016\/j.phrs.2019.104255_bib0695","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0126384","article-title":"Endoplasmic reticulum stress impairs insulin receptor signaling in the brains of obese rats","volume":"10","author":"Liang","year":"2015","journal-title":"PLoS One"},{"key":"10.1016\/j.phrs.2019.104255_bib0700","doi-asserted-by":"crossref","first-page":"362","DOI":"10.1016\/j.bbrc.2011.11.042","article-title":"Endoplasmic reticulum stress enhances \u03b3-secretase activity","volume":"416","author":"Ohta","year":"2011","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.phrs.2019.104255_bib0705","doi-asserted-by":"crossref","first-page":"2509","DOI":"10.1016\/j.neurobiolaging.2015.05.006","article-title":"Quercetin reduces eIF2\u03b1 phosphorylation by GADD34 induction","volume":"36","author":"Hayakawa","year":"2015","journal-title":"Neurobiol. Aging"},{"key":"10.1016\/j.phrs.2019.104255_bib0710","doi-asserted-by":"crossref","first-page":"314","DOI":"10.1016\/j.bbi.2015.09.012","article-title":"Chronic alpha-linolenic acid treatment alleviates age-associated neuropathology: roles of PERK\/eIF2\u03b1 signaling pathway","volume":"57","author":"Gao","year":"2016","journal-title":"Brain Behav Immun."},{"key":"10.1016\/j.phrs.2019.104255_bib0715","first-page":"1005","article-title":"Inflammation in Alzheimer disease: driving force, bystander or beneficial response?","volume":"12","author":"Wyss-Coray","year":"2006","journal-title":"Nat. Med."},{"key":"10.1016\/j.phrs.2019.104255_bib0720","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1016\/j.tins.2017.02.005","article-title":"Obesity-induced neuroinflammation: beyond the hypothalamus","volume":"40","author":"Guillemot-Legris","year":"2017","journal-title":"Trends Neurosci."},{"key":"10.1016\/j.phrs.2019.104255_bib0725","doi-asserted-by":"crossref","first-page":"1387","DOI":"10.1038\/nn1997","article-title":"Microglia: active sensor and versatile effector cells in the normal and pathologic brain","volume":"10","author":"Hanisch","year":"2007","journal-title":"Nat. Neurosci."},{"key":"10.1016\/j.phrs.2019.104255_bib0730","first-page":"2","article-title":"Microglial pathology","volume":"26","author":"Streit","year":"2014","journal-title":"Acta Neuropathol. Commun."},{"key":"10.1016\/j.phrs.2019.104255_bib0735","doi-asserted-by":"crossref","first-page":"506","DOI":"10.1016\/j.tins.2009.05.009","article-title":"Air pollution: mechanisms of neuroinflammation and CNS disease","volume":"32","author":"Block","year":"2009","journal-title":"Trends Neurosci."},{"key":"10.1016\/j.phrs.2019.104255_bib0740","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1016\/j.tins.2005.12.005","article-title":"Microglial phenotype: is the commitment reversible?","volume":"29","author":"Schwartz","year":"2006","journal-title":"Trends Neurosci."},{"key":"10.1016\/j.phrs.2019.104255_bib0745","doi-asserted-by":"crossref","first-page":"243","DOI":"10.2147\/NDT.S75546","article-title":"Neuroinflammation in Alzheimer\u2019s disease","volume":"11","author":"Zhang","year":"2015","journal-title":"Neuropsychiatr. Dis. Treat."},{"key":"10.1016\/j.phrs.2019.104255_bib0750","doi-asserted-by":"crossref","first-page":"930","DOI":"10.1016\/j.biopsych.2010.06.012","article-title":"A meta-analysis of cytokines in Alzheimer\u2019s disease","volume":"68","author":"Swardfager","year":"2010","journal-title":"Biol. Psychiatry"},{"key":"10.1016\/j.phrs.2019.104255_bib0755","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1016\/j.ceca.2017.08.004","article-title":"Calcium signaling at the endoplasmic reticulum: fine-tuning stress responses","volume":"70","author":"Carreras-Sureda","year":"2018","journal-title":"Cell Calcium"},{"key":"10.1016\/j.phrs.2019.104255_bib0760","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1016\/j.fob.2013.09.002","article-title":"Diet-induced obesity induces endoplasmic reticulum stress and insulin resistance in the amygdala of rats","volume":"11","author":"Castro","year":"2013","journal-title":"FEBS Open Bio."},{"key":"10.1016\/j.phrs.2019.104255_bib0765","doi-asserted-by":"crossref","first-page":"900","DOI":"10.1016\/j.cell.2010.02.034","article-title":"Endoplasmic reticulum stress and the inflammatory basis of metabolic disease","volume":"140","author":"Hotamisligil","year":"2010","journal-title":"Cell"},{"key":"10.1016\/j.phrs.2019.104255_bib0770","doi-asserted-by":"crossref","first-page":"446","DOI":"10.1111\/jne.12018","article-title":"Acute inhibition of central c-Jun N-terminal kinase restores hypothalamic insulin signalling and alleviates glucose intolerance in diabetic mice","volume":"25","author":"Benzler","year":"2013","journal-title":"J. Neuroendocrinol."},{"key":"10.1016\/j.phrs.2019.104255_bib0775","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1126\/science.1103160","article-title":"Endoplasmic reticulum stress links obesity, insulin action, and type 2 diabetes","volume":"306","author":"Ozcan","year":"2004","journal-title":"Science"},{"key":"10.1016\/j.phrs.2019.104255_bib0780","first-page":"22","article-title":"The transcription factor XBP1 in memory and cognition: implications in Alzheimer disease","volume":"4","author":"Ciss\u00e9","year":"2017","journal-title":"Mol. Med."},{"key":"10.1016\/j.phrs.2019.104255_bib0785","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1016\/j.bbrc.2012.05.048","article-title":"Endoplasmic reticulum stress and the onsite function of resident PTP1B","volume":"422","author":"Popov","year":"2012","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.phrs.2019.104255_bib0790","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1186\/s12974-016-0545-3","article-title":"A novel role for protein tyrosine phosphatase 1B as a positive regulator of neuroinflammation","volume":"13","author":"Song","year":"2016","journal-title":"J. Neuroinflammation"},{"key":"10.1016\/j.phrs.2019.104255_bib0795","doi-asserted-by":"crossref","DOI":"10.14348\/molcells.2017.2320","article-title":"Neuroprotective effects of protein tyrosine phosphatase 1B inhibition against ER stress- induced toxicity","volume":"40","author":"Jeon","year":"2017","journal-title":"Mol. Cells"},{"key":"10.1016\/j.phrs.2019.104255_bib0800","doi-asserted-by":"crossref","first-page":"893","DOI":"10.1111\/acel.12498","article-title":"Intranasal insulin alleviates cognitive deficits and amyloid pathology in young adult APPswe\/PS1dE9 mice","volume":"15","author":"Mao","year":"2016","journal-title":"Aging Cell"},{"key":"10.1016\/j.phrs.2019.104255_bib0805","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1001\/archneurol.2011.233","article-title":"Intranasal insulin therapy for Alzheimer disease and amnestic mild cognitive impairment: a pilot clinical trial","volume":"69","author":"Craft","year":"2012","journal-title":"Arch. Neurol."},{"key":"10.1016\/j.phrs.2019.104255_bib0810","doi-asserted-by":"crossref","first-page":"1325","DOI":"10.3233\/JAD-161256","article-title":"Effects of regular and long-acting insulin on cognition and Alzheimer\u2019s disease biomarkers: a pilot clinical trial","volume":"57","author":"Craft","year":"2017","journal-title":"J. Alzheimers Dis."},{"key":"10.1016\/j.phrs.2019.104255_bib0815","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1111\/j.1463-1326.2011.01490.x","article-title":"Intranasal administration of insulin to the brain impacts cognitive function and peripheral metabolism","volume":"14","author":"Ott","year":"2012","journal-title":"Diabetes Obes. Metab."},{"key":"10.1016\/j.phrs.2019.104255_bib0820","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1016\/j.bbr.2015.07.024","article-title":"Prophylactic liraglutide treatment prevents amyloid plaque deposition, chronic inflammation and memory impairment in APP\/PS1 mice","volume":"293","author":"McClean","year":"2015","journal-title":"Behav. Brain Res."},{"key":"10.1016\/j.phrs.2019.104255_bib0825","first-page":"4","article-title":"Exenatide promotes cognitive enhancement and positive brain metabolic changes in PS1-KI mice but has no effects in 3xTg-AD animals","volume":"2","author":"Bomba","year":"2013","journal-title":"Cell Death Dis."},{"key":"10.1016\/j.phrs.2019.104255_bib0830","doi-asserted-by":"crossref","first-page":"294","DOI":"10.1016\/j.neuroscience.2012.10.045","article-title":"The incretin analogue D-Ala2GIP reduces plaque load, astrogliosis and oxidative stress in an APP\/PS1 mouse model of Alzheimer\u2019s disease","volume":"228","author":"Duffy","year":"2013","journal-title":"Neuroscience"},{"key":"10.1016\/j.phrs.2019.104255_bib0835","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1002\/hipo.22837","article-title":"A novel GLP-1\/GIP\/Gcg triagonist reduces cognitive deficits and pathology in the 3xTg mouse model of Alzheimer\u2019s disease","volume":"28","author":"Li","year":"2018","journal-title":"Hippocampus"},{"key":"10.1016\/j.phrs.2019.104255_bib0840","first-page":"9","article-title":"The therapeutic potential of metformin in neurodegenerative diseases","volume":"19","author":"Rotermund","year":"2018","journal-title":"Front. Endocrinol."},{"key":"10.1016\/j.phrs.2019.104255_bib0845","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1016\/j.bbi.2017.12.009","article-title":"Metformin treatment prevents amyloid plaque deposition and memory impairment in APP\/PS1 mice","volume":"69","author":"Ou","year":"2018","journal-title":"Brain Behav. Immun."},{"key":"10.1016\/j.phrs.2019.104255_bib0850","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1186\/s13024-016-0082-7","article-title":"Metformin promotes tau aggregation and exacerbates abnormal behavior in a mouse model of tauopathy","volume":"11","author":"Barini","year":"2016","journal-title":"Mol. Neurodegener."},{"key":"10.1016\/j.phrs.2019.104255_bib0855","doi-asserted-by":"crossref","first-page":"6130","DOI":"10.1007\/s12035-017-0825-7","article-title":"Antidiabetic polypill improves Central pathology and cognitive impairment in a mixed model of Alzheimer\u2019s disease and type 2 diabetes","volume":"55","author":"Infante-Garcia","year":"2018","journal-title":"Mol. Neurobiol."},{"key":"10.1016\/j.phrs.2019.104255_bib0860","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1097\/WAD.0000000000000202","article-title":"Effects of the insulin sensitizer metformin in Alzheimer disease: pilot data from a randomized placebo-controlled crossover study","volume":"31","author":"Koenig","year":"2017","journal-title":"Alzheimer Dis. Assoc. Disord."},{"key":"10.1016\/j.phrs.2019.104255_bib0865","doi-asserted-by":"crossref","first-page":"239","DOI":"10.3233\/JAD-130680","article-title":"Rosiglitazone prevents amyloid-\u03b2 oligomer-induced impairment of synapse formation and plasticity via increasing dendrite and spine mitochondrial number","author":"Xu","year":"2014","journal-title":"J. Alzheimers Dis."},{"key":"10.1016\/j.phrs.2019.104255_bib0870","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1159\/000318845","article-title":"Rosiglitazone monotherapy in mild-to-moderate Alzheimer\u2019s disease: results from a randomized, double-blind, placebo-controlled phase III study","volume":"30","author":"Gold","year":"2010","journal-title":"Dement. Geriatr. Cogn. Disord."},{"key":"10.1016\/j.phrs.2019.104255_bib0875","doi-asserted-by":"crossref","first-page":"592","DOI":"10.2174\/156720511796391935","article-title":"Rosiglitazone does not improve cognition or global function when used as adjunctive therapy to AChE inhibitors in mild-to-moderate Alzheimer\u2019s disease: two phase 3 studies","volume":"8","author":"Harrington","year":"2011","journal-title":"Curr. Alzheimer Res."},{"key":"10.1016\/j.phrs.2019.104255_bib0880","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1002\/ana.24439","article-title":"Effect of pioglitazone medication on the incidence of dementia","volume":"78","author":"Heneka","year":"2015","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.phrs.2019.104255_bib0885","first-page":"92","article-title":"Combination treatment with leptin and pioglitazone in a mouse model of Alzheimer\u2019s disease","volume":"3","author":"Fernandez-Martos","year":"2016","journal-title":"Alzheimers Dement."},{"issue":"68","key":"10.1016\/j.phrs.2019.104255_bib0890","first-page":"45","article-title":"A randomized pilot clinical trial of the safety of pioglitazone in treatment of patients with Alzheimer disease","volume":"68","author":"Geldmacher","year":"2011","journal-title":"Arch. Neurol."},{"key":"10.1016\/j.phrs.2019.104255_bib0895","doi-asserted-by":"crossref","first-page":"1416","DOI":"10.1345\/aph.1Q238","article-title":"Rosiglitazone and pioglitazone for the treatment of Alzheimer\u2019s disease","volume":"45","author":"Miller","year":"2011","journal-title":"Ann. Pharmacother."},{"key":"10.1016\/j.phrs.2019.104255_bib0900","doi-asserted-by":"crossref","first-page":"1626","DOI":"10.1016\/j.neurobiolaging.2009.10.009","article-title":"Efficacy of PPAR-gamma agonist pioglitazone in mild Alzheimer disease","volume":"32","author":"Sato","year":"2011","journal-title":"Neurobiol. Aging"},{"key":"10.1016\/j.phrs.2019.104255_bib0905","doi-asserted-by":"crossref","first-page":"1039","DOI":"10.1016\/j.bbrc.2016.04.012","article-title":"PPAR\u03b3 agonist pioglitazone improves cerebellar dysfunction at pre-a\u03b2 deposition stage in APPswe\/PS1dE9 Alzheimer\u2019s disease model mice","volume":"473","author":"Toba","year":"2016","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.phrs.2019.104255_bib0910","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1016\/j.ejmech.2006.09.019","article-title":"A review of anti-infective and anti-inflammatory chalcones","volume":"42","author":"Nowakowska","year":"2007","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.phrs.2019.104255_bib0915","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1517\/13543776.2014.995627","article-title":"Potential pharmacological uses of chalcones: a patent review (from June 2011-2014)","volume":"25","author":"Matos","year":"2015","journal-title":"Expert Opin. Ther. Pat."},{"key":"10.1016\/j.phrs.2019.104255_bib0920","doi-asserted-by":"crossref","first-page":"10926","DOI":"10.3390\/ijms140610926","article-title":"Mechanisms by which licochalcone e exhibits potent anti-inflammatory properties: studies with phorbol ester-treated mouse skin and lipopolysaccharide-stimulated murine macrophagesv","volume":"14","author":"Lee","year":"2013","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.phrs.2019.104255_bib0925","doi-asserted-by":"crossref","first-page":"310","DOI":"10.1016\/j.apsb.2015.05.005","article-title":"The antiviral and antimicrobial activities of licorice, a widely used Chinese herb","volume":"5","author":"Wang","year":"2015","journal-title":"Acta Pharm. Sin. B"},{"key":"10.1016\/j.phrs.2019.104255_bib0930","doi-asserted-by":"crossref","first-page":"1314","DOI":"10.1016\/j.jnutbio.2011.07.012","article-title":"Licochalcone E activates Nrf2\/antioxidant response element signaling pathway in both neuronal and microglial cells: therapeutic relevance to neurodegenerative disease","volume":"23","author":"Kim","year":"2012","journal-title":"J. Nutr. Biochem."},{"key":"10.1016\/j.phrs.2019.104255_bib0935","doi-asserted-by":"crossref","first-page":"653","DOI":"10.3109\/08923973.2013.834929","article-title":"Attenuation of allergic airway inflammation in A murine model of asthma by licochalcone A","volume":"35","author":"Chu","year":"2013","journal-title":"Immunopharmacol. Immunotoxicol."},{"key":"10.1016\/j.phrs.2019.104255_bib0940","first-page":"2653","article-title":"Modulation of bcl-2 and cytotoxicity by licochalcone-A, a novel estrogenic flavonoid","volume":"20","author":"Rafi","year":"2000","journal-title":"Anticancer Res."},{"key":"10.1016\/j.phrs.2019.104255_bib0945","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1016\/j.ejmech.2016.06.008","article-title":"Neuroprotective effect of synthetic chalcone derivatives as competitive dual inhibitors against \u03bc-calpain and cathepsin B through the downregulation of tau phosphorylation and insoluble a\u03b2 peptide formation","volume":"121","author":"Jeon","year":"2016","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.phrs.2019.104255_bib0950","doi-asserted-by":"crossref","first-page":"1102","DOI":"10.1016\/j.bmc.2018.01.030","article-title":"Design, synthesis and evaluation of 4\u2019-OH-flurbiprofen-chalcone hybrids as potential multifunctional agents for Alzheimer\u2019s disease treatment","volume":"26","author":"Cao","year":"2018","journal-title":"Bioorg. Med. Chem."},{"key":"10.1016\/j.phrs.2019.104255_bib0955","doi-asserted-by":"crossref","first-page":"41795","DOI":"10.1038\/srep41795","article-title":"Pharmacological inhibition of c-jun N-terminal kinase reduces food intake and sensitizes leptin\u2019s anorectic signaling actions","volume":"7","author":"Gao","year":"2017","journal-title":"Sci. Rep."},{"key":"10.1016\/j.phrs.2019.104255_bib0960","doi-asserted-by":"crossref","first-page":"2463","DOI":"10.1172\/JCI79742","article-title":"Hyperglycemia modulates extracellular amyloid-\u03b2 concentrations and neuronal activity in vivo","volume":"125","author":"Macauley","year":"2015","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.phrs.2019.104255_bib0965","doi-asserted-by":"crossref","first-page":"660","DOI":"10.1038\/nrn4019","article-title":"Hippocampal insulin resistance and cognitive dysfunction","volume":"16","author":"Biessels","year":"2015","journal-title":"Nat. Rev. Neurosci."},{"key":"10.1016\/j.phrs.2019.104255_bib0970","doi-asserted-by":"crossref","first-page":"15056","DOI":"10.1038\/nrdp.2015.56","article-title":"Alzheimer\u2019s disease","volume":"1","author":"Masters","year":"2015","journal-title":"Nat. Rev. Dis. Primers."},{"key":"10.1016\/j.phrs.2019.104255_bib0975","doi-asserted-by":"crossref","first-page":"633","DOI":"10.1212\/WNL.0b013e318264e380","article-title":"Serum ceramides increase the risk of Alzheimer disease: the women\u2019s health and aging study II","volume":"79","author":"Mielke","year":"2012","journal-title":"Neurology"},{"key":"10.1016\/j.phrs.2019.104255_bib0980","doi-asserted-by":"crossref","first-page":"290","DOI":"10.2174\/18715273113126660135","article-title":"Molecular linkages between diabetes and Alzheimer\u2019s disease: current scenario and future prospects","volume":"13","author":"Dar","year":"2014","journal-title":"CNS Neurol. Disord. Drug Targets"},{"key":"10.1016\/j.phrs.2019.104255_bib0985","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1016\/j.neuropharm.2017.11.037","article-title":"Intranasal insulin in Alzheimer\u2019s disease: food for thought","volume":"136","author":"Chapman","year":"2018","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.phrs.2019.104255_bib0990","doi-asserted-by":"crossref","first-page":"897","DOI":"10.3233\/JAD-141791","article-title":"Long-acting intranasal insulin detemir improves cognition for adults with mild cognitive impairment or early-stage Alzheimer\u2019s disease dementia","volume":"44","author":"Claxton","year":"2015","journal-title":"J. Alzheimers Dis."},{"key":"10.1016\/j.phrs.2019.104255_bib0995","doi-asserted-by":"crossref","first-page":"1","DOI":"10.2165\/00023210-200822010-00001","article-title":"The role of peroxisome proliferator-activated receptor-gamma (PPARgamma) in Alzheimer\u2019s disease: therapeutic implications","volume":"22","author":"Jiang","year":"2008","journal-title":"CNS Drugs"},{"key":"10.1016\/j.phrs.2019.104255_bib1000","doi-asserted-by":"crossref","first-page":"13701","DOI":"10.1523\/JNEUROSCI.2107-12.2012","article-title":"Glucagon-like peptide-1 cleavage product GLP-1(9-36) amide rescues synaptic plasticity and memory deficits in Alzheimer\u2019s disease model mice","volume":"32","author":"Ma","year":"2012","journal-title":"J. Neurosci."},{"key":"10.1016\/j.phrs.2019.104255_bib1005","doi-asserted-by":"crossref","first-page":"1327","DOI":"10.1038\/mp.2016.230","article-title":"Molecular interaction between type 2 diabetes and Alzheimer\u2019s disease through cross-seeding of protein misfolding","volume":"22","author":"Moreno-Gonzalez","year":"2017","journal-title":"Mol. Psychiatry"},{"key":"10.1016\/j.phrs.2019.104255_bib1010","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1016\/j.tem.2010.05.005","article-title":"Alzheimer\u2019s disease: brain expression of a metabolic disorder?","volume":"21","author":"Merlo","year":"2010","journal-title":"Trends Endocrinol. Metab."},{"key":"10.1016\/j.phrs.2019.104255_bib1015","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1186\/1742-2094-6-41","article-title":"ER stress in alzheimer\u2019s disease: a novel neuronal trigger for inflammation and alzheimer\u2019s pathology","volume":"6","author":"Salminen","year":"2009","journal-title":"J Neuroinflammation"},{"key":"10.1016\/j.phrs.2019.104255_bib1020","doi-asserted-by":"crossref","first-page":"9078","DOI":"10.1523\/JNEUROSCI.1071-09.2009","article-title":"Beta-amyloid oligomers induce phosphorylation of tau and inactivation of insulin receptor substrate via c-jun N-terminal kinase signaling: suppression by omega-3 fatty acids and curcumin","volume":"29","author":"Ma","year":"2009","journal-title":"J. Neurosci."},{"key":"10.1016\/j.phrs.2019.104255_bib1025","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1016\/j.intimp.2009.01.031","article-title":"Glycyrrhiza inflata-derived chalcones, licochalcone A, licochalcone B and licochalcone D, inhibit phosphorylation of NF-kappaB p65 in LPS signaling pathway","volume":"9","author":"Furusawa","year":"2009","journal-title":"Int. Immunopharmacol."},{"key":"10.1016\/j.phrs.2019.104255_bib1030","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1158\/1940-6207.CAPR-13-0117","article-title":"A natural inhibitor of c-jun N-terminal kinase 1","volume":"7","author":"Yao","year":"2014","journal-title":"Cancer Prev. Res. (Phila)"},{"key":"10.1016\/j.phrs.2019.104255_bib1035","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1016\/j.neuro.2013.08.012","article-title":"Neuroprotective effects of liquiritigenin isolated from licorice roots on glutamate-induced apoptosis in hippocampal neuronal cells","volume":"39","author":"Yang","year":"2013","journal-title":"Neurotoxicology"},{"key":"10.1016\/j.phrs.2019.104255_bib1040","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1007\/s00401-015-1527-8","article-title":"Neuroinflammation impairs adaptive structural plasticity of dendritic spines in a preclinical model of Alzheimer\u2019s disease","volume":"131","author":"Zou","year":"2016","journal-title":"Acta Neuropathol."},{"key":"10.1016\/j.phrs.2019.104255_bib1045","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1056\/NEJMoa1705971","article-title":"Trial of solanezumab for mild dementia due to Alzheimer\u2019s disease","volume":"378","author":"Honig","year":"2018","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.phrs.2019.104255_bib1050","doi-asserted-by":"crossref","first-page":"679","DOI":"10.1007\/s00401-014-1328-5","article-title":"Abnormal serine phosphorylation of insulin receptor substrate 1 is associated with tau pathology in Alzheimer\u2019s disease and tauopathies","volume":"128","author":"Yarchoan","year":"2014","journal-title":"Acta Neuropathol."},{"key":"10.1016\/j.phrs.2019.104255_bib1055","doi-asserted-by":"crossref","first-page":"789","DOI":"10.3233\/JAD-122308","article-title":"Sex and ApoE genotype differences in treatment response to two doses of intranasal insulin in adults with mild cognitive impairment or Alzheimer\u2019s disease","volume":"35","author":"Claxton","year":"2013","journal-title":"J. Alzheimers Dis."},{"key":"10.1016\/j.phrs.2019.104255_bib1060","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1016\/j.neurobiolaging.2005.03.016","article-title":"Effects of intranasal insulin on cognition in memory-impaired older adults: modulation by APOE genotype","author":"Reger","year":"2006","journal-title":"Neurobiol. Aging"},{"key":"10.1016\/j.phrs.2019.104255_bib1065","doi-asserted-by":"crossref","first-page":"323","DOI":"10.3233\/JAD-2008-13309","article-title":"Intranasal insulin administration dose-dependently modulates verbal memory and plasma amyloid-beta in memoryimpaired older adults","volume":"13","author":"Reger","year":"2008","journal-title":"J. Alzheimer Dis."},{"key":"10.1016\/j.phrs.2019.104255_bib1070","doi-asserted-by":"crossref","first-page":"440","DOI":"10.1212\/01.WNL.0000265401.62434.36","article-title":"Intranasal insulin improves cognition and modulates beta-amyloid in early AD","volume":"70","author":"Reger","year":"2008","journal-title":"Neurology"}],"container-title":["Pharmacological Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1043661818318115?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1043661818318115?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,19]],"date-time":"2025-10-19T21:58:44Z","timestamp":1760911124000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1043661818318115"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,7]]},"references-count":214,"alternative-id":["S1043661818318115"],"URL":"https:\/\/doi.org\/10.1016\/j.phrs.2019.104255","relation":{},"ISSN":["1043-6618"],"issn-type":[{"value":"1043-6618","type":"print"}],"subject":[],"published":{"date-parts":[[2019,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"A metabolic perspective of late onset Alzheimer\u2019s disease","name":"articletitle","label":"Article Title"},{"value":"Pharmacological Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.phrs.2019.104255","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"104255"}}